SUSMED,Inc. (TYO:4263)

Market Cap	5.87B -61.4%
Revenue (ttm)	497.00M +7.6%
Net Income	-382.00M
EPS	-22.67
Shares Out	16.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	95,000
Open	354.00
Previous Close	347.00
Day's Range	347.00 - 354.00
52-Week Range	340.00 - 1,231.00
Beta	1.14
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2026

About SUSMED,Inc.

SUSMED,Inc. develops and sells therapeutic applications and platform systems in Japan. It operates through DTx product business, and DTx platform business segments. The company develops smartphone-based therapeutic apps for diseases, such as insomnia, breast cancer, and kidney disease. It also develops and provides clinical trial systems with blockchain technology. In addition, the company offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Employees: 50
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4263

Financial Performance

In fiscal year 2026, SUSMED,Inc.'s revenue was 497.00 million, an increase of 7.58% compared to the previous year's 462.00 million. Losses were -382.00 million, 28.2% more than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 26, 2026

Data Sources Report a data error